Journal Information
Vol. 15. Issue 1.
Pages 96 (January - February 2011)
Vol. 15. Issue 1.
Pages 96 (January - February 2011)
Letter to the editor
Open Access
Fosfomycin in vitro resistance of Escherichia coli from the community
Visits
2932
Caroline M. Biondo1, Jaime L. Rocha2, Felipe Francisco Tuon3,
1 Division of Infectious and Parasitic Diseases, Hospital Universitario Evangelico de Curitiba, Curitiba, PR, Brazil - MS
2 Division of Microbiology, Frischmann Aisengart/DASA Medicina Diagnóstica, Curitiba, PR, Brazil - MD
3 Hospital Universitário Evangélico de Curitiba
This item has received

Under a Creative Commons license
Article information
Full text is only available in PDF
References
[1.]
CLSI.
Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20.
Clinical and Laboratory Standards Institute, (2010),
[2.]
M. Popovic, D. Steinort, S. Pillai, C. Joukhadar.
Fosfomycin: an old, new friend?.
Eur J Clin Microbiol Infect Dis, 29 (2010), pp. 127-142
[3.]
E. Calbo, V. Romani, M. Xercavins, et al.
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
J Antimicrob Chemother, 57 (2006), pp. 780-783
[4.]
S. Superti, C.A. Dias, P.A. d‘Azevedo.
In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis.
Braz J Infect Dis, 13 (2009), pp. 123-124
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools